Recombinant Staphylococcus aureus Probable cysteine desulfurase (csd)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will ship the format in stock. If you have special format requirements, please specify them when ordering.
Lead Time
Delivery time varies by purchasing method and location. Consult your local distributor for specific delivery times. All proteins are shipped with blue ice packs by default. Request dry ice in advance for an extra fee.
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you have a specific tag type requirement, please inform us, and we will prioritize development of the specified tag.
Synonyms
csd; SA0776; Probable cysteine desulfurase; EC 2.8.1.7
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-413
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Staphylococcus aureus (strain N315)
Target Names
csd
Target Protein Sequence
MAEHSFDVNE VIKDFPILDQ KVNGKRLAYL DSTATSQTPM QVLNVLEDYY KRYNSNVHRG VHTLGSLATD GYENARETVR RFINAKYFEE IIFTRGTTAS INLVAHSYGD ANVEEGDEIV VTEMEHHANI VPWQQLAKRK NATLKFIPMT ADGELNIEDI KQTINDKTKI VAIAHISNVL GTINDVKTIA EIAHQHGAII SVDGAQAAPH MKLDMQEMNA DFYSFSGHKM LGPTGIGVLF GKRELLQKME PIEFGGDMID FVSKYDATWA DLPTKFEAGT PLIAQAIGLA EAIRYLERIG FDAIHKYEQE LTIYAYEQMS AIEGIEIYGP PKDRRAGVIT FNLQDVHPHD VATAVDTEGV AVRAGHHCAQ PLMKWLNVSS TARASFYIYN TKEDIDQLIN ALKQTKEFFS YEF
Uniprot No.

Target Background

Function
Catalyzes the removal of elemental sulfur and selenium from L-cysteine, L-cystine, L-selenocysteine, and L-selenocystine to produce L-alanine.
Database Links

KEGG: sau:SA0776

Protein Families
Class-V pyridoxal-phosphate-dependent aminotransferase family, Csd subfamily

Q&A

What is Staphylococcus aureus cysteine desulfurase and what role does it play in bacterial metabolism?

Staphylococcus aureus cysteine desulfurase (SufS) is a pyridoxal 5′-phosphate (PLP)-dependent enzyme that catalyzes the first step in iron-sulfur (Fe-S) cluster biogenesis in the SUF-like pathway. SufS abstracts a sulfur atom from a free cysteine substrate, forming a persulfide intermediate on a conserved cysteine residue while releasing alanine as a byproduct . This enzyme is essential for S. aureus viability as it provides sulfur for the assembly of Fe-S clusters, which are critical cofactors for numerous proteins involved in diverse cellular processes including respiration, DNA replication, and metabolism .

Unlike many Gram-negative bacteria that possess redundant Fe-S cluster biogenesis pathways, Gram-positive bacteria like S. aureus typically rely solely on the SUF-like pathway, making SufS an essential protein . This exclusivity highlights its potential as a therapeutic target for treating S. aureus infections.

How does S. aureus SufS compare structurally and functionally to homologous proteins in other bacterial species?

S. aureus SufS (SaSufS) shows high structural congruence to its Bacillus subtilis homologue (BsSufS), both being classified as type II cysteine desulfurases . X-ray crystallography has revealed that SaSufS contains a PLP cofactor, which is essential for its catalytic activity .

Cross-species activity experiments have demonstrated that cysteine desulfurase activity levels are dictated by the SufS homologue, as BsSufU and SaSufU can be interchanged without significantly altering the characteristic stimulation patterns of their respective SufS enzymes .

What experimental methods are commonly used to assess cysteine desulfurase activity?

Methodologically, researchers typically assess cysteine desulfurase activity using one of several approaches:

  • Methylene blue assay: Measures sulfide production by monitoring the formation of methylene blue after reaction with N,N-dimethyl-p-phenylenediamine in the presence of ferric chloride.

  • Alanine production assay: Quantifies the alanine byproduct of the desulfuration reaction, as demonstrated in the comparative studies of SaSufS and BsSufS .

  • UV-Vis spectroscopy: Monitors changes in the PLP cofactor's absorption spectrum during the reaction cycle .

For the SufSU complex, activity measurements typically involve:

  • Using defined concentrations of purified recombinant proteins

  • Including a reducing agent (such as TCEP or DTT) to regenerate cysteine desulfurases for subsequent substrate turnover

  • Controlling reaction time and substrate concentration to avoid substrate inhibition, which occurs at ≥1 mM cysteine for BsSufSU

In studies comparing SaSufS and BsSufS, reactions typically contain 0.5 μM SufS, 2.5 μM SufU, 500 μM cysteine, and 2 mM TCEP, with reactions run for 7 minutes .

What is the relationship between cysteine desulfurase and bacterial stress response mechanisms?

Cysteine desulfurase plays an indirect but crucial role in bacterial stress responses, particularly against oxidative stress. During infection, S. aureus encounters reactive oxygen species (ROS) from host neutrophils as part of the respiratory burst . These ROS can damage numerous cellular components, including DNA.

While not part of the primary stress response, the Fe-S clusters assembled through the SufS-initiated pathway are essential cofactors for DNA repair enzymes that address oxidative damage . Additionally, the SUF-like pathway in S. aureus may be upregulated under oxidative stress conditions to replace damaged Fe-S clusters in essential proteins.

The importance of functional Fe-S cluster biogenesis is underscored by the fact that people with chronic granulomatous disease, who cannot generate ROS through their NADPH oxidase, have a high incidence of S. aureus infections . This suggests that the pathogen's stress response mechanisms, including those supported by Fe-S cluster-containing proteins, are crucial for withstanding host defenses.

How do the kinetic properties of S. aureus SufS differ from those of other bacterial cysteine desulfurases?

The kinetic properties of SaSufS show notable differences compared to other bacterial cysteine desulfurases, particularly in how its activity is stimulated by its sulfur acceptor protein. The most striking difference is observed in the comparative stimulation factors between S. aureus and B. subtilis systems.

The table below summarizes the activity measurements comparing SaSufS and BsSufS with their respective SufU proteins:

SufS SourceNo SufU added (basal SufS activity)SaSufU addedBsSufU added
alanine produced (nmol)alanine produced (nmol)stimulation factor
SaSufS activity4 ± 26 ± 21.5
BsSufS activity2 ± 130 ± 1015

This data reveals several important kinetic insights :

  • The basal activities of SaSufS and BsSufS (without SufU) are comparable, with SaSufS showing slightly higher activity.

  • BsSufS activity increases 15-fold with either BsSufU or SaSufU, while SaSufS activity increases only 1.5-fold with SaSufU and shows no stimulation with BsSufU.

  • The stimulation pattern is determined by the SufS homologue rather than the SufU partner, suggesting fundamental differences in how these enzymes process their substrate.

These differences may reflect evolutionary adaptations to different physiological conditions or cellular environments, and understanding these variations could provide insights into developing species-specific inhibitors .

What molecular mechanisms might explain the lower stimulation of S. aureus SufS by SufU compared to homologous systems?

Several hypotheses might explain the significantly lower stimulation of SaSufS by SufU compared to the B. subtilis system:

  • Scaffold complex requirement: The SufBCD complex, which serves as the Fe-S cluster scaffold, may be required for full stimulation of SaSufS activity. In the E. coli SUF pathway, SufS activity is stimulated 8-fold by SufE (analogous to SufU), but this increases to 32-fold in the presence of SufBCD . A similar dependency might exist in the S. aureus system, where SufBCD may be necessary for optimal SaSufS stimulation.

  • Persulfide transfer mechanism: The underlying mechanism of persulfide transfer from SaSufS to SaSufU may differ from that in B. subtilis, resulting in less efficient sulfur mobilization and consequently lower stimulation .

  • Structural differences: Despite high sequence identity, subtle structural differences between SaSufS and BsSufS might affect the protein-protein interactions with SufU, altering the efficiency of sulfur transfer.

  • Regulatory adaptations: The lower stimulation might reflect an adaptation in S. aureus to regulate Fe-S cluster biogenesis more stringently, possibly in response to its pathogenic lifestyle and the need to maintain iron homeostasis during infection.

Research to distinguish between these possibilities would involve detailed structural studies of the SaSufSU complex, mutagenesis of key residues at the interface between the proteins, and reconstitution experiments incorporating the SufBCD complex .

What structural features of S. aureus SufS might be targeted for antimicrobial development?

The essential nature of SufS in S. aureus makes it an attractive target for antimicrobial development. Several structural features offer potential sites for inhibitor design:

  • Active site pocket: The PLP-binding pocket and cysteine substrate binding site are highly conserved and essential for catalytic function. Molecules that compete with either PLP or cysteine could inhibit SufS activity. X-ray crystallography of SaSufS has revealed an unusual electron density at the phosphate group of the PLP cofactor, suggesting a unique pentacoordinate species that might be exploited for specific targeting .

  • SufS-SufU interface: The protein-protein interaction surface between SufS and SufU represents another potential target. Disrupting this interaction would prevent sulfur transfer and subsequent Fe-S cluster formation. The relatively lower stimulation of SaSufS by SufU suggests possible structural differences at this interface compared to other bacterial systems, which might allow for selective targeting .

  • Zinc-binding site in SufU: SaSufU contains an essential Zn²⁺ ion that facilitates the formation of the SufSU complex through a ligand-swapping mechanism . Molecules that interfere with zinc coordination could potentially disrupt the SufSU complex formation.

  • Persulfide transfer channel: The pathway through which the persulfide is transferred from SufS to SufU could be targeted to block sulfur mobilization.

The high structural congruence between SaSufS and BsSufS suggests similar mechanisms of action, but the unexpected differences in activity stimulation highlight potential species-specific features that could be exploited for selective targeting of S. aureus .

How does the SUF-like pathway in S. aureus interact with DNA repair mechanisms during infection?

The SUF-like pathway in S. aureus has important connections to DNA repair mechanisms that contribute to bacterial survival during infection:

  • Fe-S clusters in DNA repair enzymes: Many DNA repair proteins require Fe-S clusters as cofactors. By providing Fe-S clusters, the SUF-like pathway indirectly supports DNA repair mechanisms that address damage caused by host-generated ROS .

  • SOS response coordination: In S. aureus, the SOS response is a global transcriptional reaction to DNA damage that leads to cell cycle arrest and DNA repair initiation . This response can be triggered by various DNA-damaging agents, including ROS and certain antibiotics . While not directly part of the SOS regulon, the SUF-like pathway likely responds to the same stressors and works in parallel to maintain cellular functions during stress conditions.

  • Oxidative stress management: During phagocytosis by neutrophils, S. aureus is exposed to ROS as part of the respiratory burst . The SUF-like pathway may be particularly important under these conditions to replace damaged Fe-S clusters and maintain the function of essential metabolic and DNA repair enzymes.

The importance of these interconnections is evidenced by the high incidence of S. aureus infections in people with chronic granulomatous disease, who lack functional NADPH oxidase and cannot generate ROS as part of their immune defense . This suggests that S. aureus has evolved robust mechanisms, including the SUF-like pathway, to withstand oxidative stress during infection.

Understanding how the SUF-like pathway interacts with DNA repair mechanisms could provide insights into bacterial persistence during infection and potential strategies to sensitize S. aureus to host defenses and antibiotics .

What are the implications of cross-species activity patterns between SufS and SufU for understanding the evolution of Fe-S cluster biogenesis systems?

The cross-species activity analysis of SufS and SufU from S. aureus and B. subtilis reveals intriguing patterns that inform our understanding of the evolution of Fe-S cluster biogenesis systems:

These evolutionary insights could inform both fundamental understanding of bacterial physiology and applied efforts to develop species-specific inhibitors of the SUF-like pathway for antimicrobial therapy .

What are the key considerations for expressing and purifying recombinant S. aureus SufS for biochemical studies?

Successful expression and purification of recombinant S. aureus SufS requires careful attention to several factors:

  • Expression system selection: Most studies use E. coli BL21(DE3) or similar strains for heterologous expression of SaSufS. The gene should be codon-optimized for expression in E. coli and cloned into a vector with an appropriate promoter (typically T7) and affinity tag (His6 or similar) .

  • PLP cofactor retention: Since SufS is a PLP-dependent enzyme, expression and purification conditions should maintain cofactor association. Adding PLP (typically 50-100 μM) to the growth medium and purification buffers helps ensure high cofactor occupancy in the purified protein .

  • Solubility and folding: Expression at lower temperatures (16-18°C) after IPTG induction can improve proper folding and solubility. Including glycerol (5-10%) in purification buffers also helps maintain solubility.

  • Reducing conditions: Including a reducing agent (such as DTT or TCEP, typically 1-5 mM) in purification buffers helps prevent unwanted oxidation of the catalytic cysteine residue .

  • Buffer composition: A typical buffer system for SufS purification might include 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 5% glycerol, and 1 mM TCEP .

  • Quality control: UV-vis spectroscopy should be used to confirm the presence of the PLP cofactor (absorption maximum around 420 nm). Size-exclusion chromatography helps ensure the protein is properly folded and not aggregated.

  • Activity verification: A simple activity assay, such as measuring alanine production from cysteine, should be performed to confirm that the purified protein is catalytically active .

Following these considerations will help ensure that the recombinant SaSufS obtained is structurally intact and functionally active for subsequent biochemical and structural studies.

How can researchers effectively investigate the interaction between S. aureus SufS and SufU proteins?

Investigating the interaction between S. aureus SufS and SufU requires multiple complementary approaches:

  • Protein-protein interaction assays:

    • Surface plasmon resonance (SPR) to determine binding kinetics and affinity

    • Isothermal titration calorimetry (ITC) to measure thermodynamic parameters of binding

    • Pull-down assays using tagged proteins to confirm physical interaction

    • Size-exclusion chromatography to assess complex formation

  • Functional assays:

    • Cysteine desulfurase activity measurements comparing SufS alone versus the SufSU complex

    • Persulfide formation detection using alkylating agents and mass spectrometry

    • Zinc binding fluorescence assays for SufU to assess the role of zinc in complex formation

  • Structural characterization:

    • X-ray crystallography of the SufSU complex to determine interaction interfaces

    • Small-angle X-ray scattering (SAXS) to study the complex in solution

    • Hydrogen-deuterium exchange mass spectrometry to identify regions involved in binding

    • Site-directed mutagenesis of predicted interface residues followed by interaction and activity assays

  • Cross-species experiments:

    • Comparing interactions between SufS and SufU from different species (e.g., S. aureus and B. subtilis) to identify species-specific features

    • Creating chimeric proteins combining domains from different species to pinpoint regions responsible for species-specific behaviors

  • In vivo studies:

    • Bacterial two-hybrid assays to confirm interaction in a cellular context

    • Co-immunoprecipitation from bacterial lysates to verify native interaction

By combining these approaches, researchers can develop a comprehensive understanding of the SufS-SufU interaction, including the molecular basis for the unexpectedly low stimulation of SaSufS by SufU compared to other bacterial systems .

What methods are available for assessing the impact of SUF-like pathway inhibition on S. aureus viability and virulence?

Researchers can employ several methodologies to evaluate how inhibition of the SUF-like pathway affects S. aureus viability and virulence:

  • Genetic approaches:

    • Construction of conditional mutants using inducible promoters to control expression of SufS or SufU

    • CRISPR interference (CRISPRi) to achieve tunable repression of SUF-like pathway genes

    • Transposon mutagenesis to identify genetic interactions with the SUF-like pathway

  • Chemical biology methods:

    • Small molecule screening to identify inhibitors of SufS enzymatic activity

    • Structure-based drug design targeting the SufS active site or SufS-SufU interface

    • Compound library screening using bacterial growth inhibition as a readout

  • In vitro viability assessments:

    • Minimum inhibitory concentration (MIC) determination for pathway inhibitors

    • Time-kill kinetics to assess the rate of bacterial killing

    • Synergy testing with conventional antibiotics to identify potential combination therapies

    • Growth curve analysis under various stress conditions (oxidative stress, iron limitation)

  • Cellular stress response measurements:

    • Quantification of intracellular iron-sulfur cluster content using whole-cell EPR spectroscopy

    • Measurement of activities of Fe-S-dependent enzymes as markers of pathway function

    • Assessment of ROS sensitivity following pathway inhibition

    • Analysis of SOS response activation using reporter constructs

  • Infection models:

    • Animal infection models to assess virulence of strains with compromised SUF-like pathway

    • Ex vivo neutrophil killing assays to evaluate bacterial survival against host defenses

    • Biofilm formation capacity following pathway inhibition

    • Intracellular survival in cell culture models

The essentiality of the SUF-like pathway in S. aureus makes it challenging to create complete knockout mutants, necessitating these alternative approaches to understand how pathway inhibition impacts bacterial physiology and pathogenesis .

How can researchers differentiate between the contributions of different components of the Fe-S cluster biogenesis machinery in S. aureus?

Differentiating the contributions of individual components in the Fe-S cluster biogenesis machinery requires sophisticated experimental approaches:

  • Component-specific depletion:

    • Inducible expression systems to create conditional mutants of individual components

    • CRISPRi to achieve titratable repression of specific genes

    • Controlled proteolysis using degron tags to rapidly deplete specific proteins

  • Biochemical reconstitution:

    • In vitro reconstitution of the complete pathway with purified components

    • Systematic omission of individual components to determine their specific roles

    • Addition of components in different orders to establish the sequence of events

    • Cross-complementation with components from related organisms to identify functional conservation

  • Protein-protein interaction mapping:

    • Bacterial two-hybrid or BACTH screening to identify all interaction partners

    • Co-immunoprecipitation followed by mass spectrometry to identify native complexes

    • Chemical crosslinking coupled with mass spectrometry to capture transient interactions

    • Förster resonance energy transfer (FRET) to visualize interactions in real-time

  • Functional readouts:

    • Activity assays for Fe-S-dependent enzymes (e.g., aconitase) as markers of successful cluster assembly

    • Measurement of persulfide formation on different pathway components

    • Iron and sulfur incorporation assays using radioactive isotopes (^55Fe, ^35S)

    • Analysis of the kinetics of cluster assembly and transfer

  • Structural analysis:

    • Cryo-electron microscopy of the multi-protein complexes involved in cluster assembly

    • X-ray crystallography of individual components and subcomplexes

    • Hydrogen-deuterium exchange mass spectrometry to map interaction surfaces

These approaches would help determine whether the lower stimulation of SaSufS by SufU compared to BsSufS is due to intrinsic properties of these proteins or whether additional factors like SufBCD are required for full activity, as hypothesized based on comparison with the E. coli SUF system .

What are common challenges in measuring cysteine desulfurase activity and how can they be addressed?

Measuring cysteine desulfurase activity presents several technical challenges that researchers should be aware of:

  • Enzyme instability and oxidation:

    • Challenge: The catalytic cysteine residue in SufS is susceptible to oxidation, leading to activity loss during purification and storage.

    • Solution: Maintain reducing conditions throughout purification and storage using DTT or TCEP (typically 1-5 mM). Perform activity assays immediately after thawing protein samples .

  • PLP cofactor loss:

    • Challenge: The PLP cofactor can dissociate during purification, resulting in decreased activity.

    • Solution: Supplement purification buffers with PLP (50-100 μM) and dialyze against PLP-containing buffer before activity assays .

  • Substrate inhibition:

    • Challenge: High concentrations of cysteine (≥1 mM) can inhibit enzyme activity, particularly for the BsSufSU system .

    • Solution: Use cysteine concentrations below 1 mM (typically 500 μM) for initial rate measurements and perform substrate titrations to determine the optimal concentration range .

  • Product detection sensitivity:

    • Challenge: Direct detection of H₂S is challenging due to its volatility and reactivity.

    • Solution: Monitor alternative reaction products like alanine, or use the methylene blue assay with immediate sample processing to minimize H₂S loss .

  • Non-linear reaction kinetics:

    • Challenge: The reaction may not maintain linearity over extended periods, especially when SufU is present .

    • Solution: Establish the linear range for each experimental condition and select appropriate time points for measurements. For comparing different systems (e.g., SaSufS vs. BsSufS), use fixed time points outside the linear range to assess total substrate turnover capacity .

  • Background sulfide generation:

    • Challenge: Spontaneous degradation of cysteine can produce background sulfide levels.

    • Solution: Include appropriate no-enzyme controls and subtract background values from experimental measurements.

By addressing these challenges through careful experimental design, researchers can obtain reliable measurements of cysteine desulfurase activity that allow meaningful comparisons between different systems .

How can researchers distinguish between the roles of SufS and other potential cysteine desulfurases in S. aureus?

Distinguishing between SufS and other potential cysteine desulfurases in S. aureus requires a multi-faceted approach:

  • Bioinformatic analysis:

    • Comprehensive genome analysis to identify all potential cysteine desulfurase homologs in S. aureus

    • Phylogenetic comparison with characterized cysteine desulfurases from other organisms

    • Domain architecture analysis to classify candidates as type I or type II cysteine desulfurases

  • Genetic approaches:

    • Individual gene knockouts or conditional depletion systems for each candidate

    • Phenotypic analysis of mutants under various conditions (normal growth, oxidative stress, iron limitation)

    • Complementation studies to determine functional redundancy

    • Double or triple mutant construction to identify synthetic interactions

  • Biochemical characterization:

    • Purification and enzymatic characterization of all candidate proteins

    • Substrate specificity analysis (e.g., preference for cysteine vs. selenocysteine)

    • Determination of kinetic parameters (kcat, KM) for each enzyme

    • Analysis of stimulation by potential partner proteins like SufU

  • Protein interaction studies:

    • Identification of specific interaction partners for each cysteine desulfurase

    • Co-purification assays to determine if different cysteine desulfurases associate with distinct cellular pathways

    • Bacterial two-hybrid screens to map the interaction network of each enzyme

  • Cellular localization:

    • Fluorescent protein fusions to determine subcellular localization

    • Fractionation studies to identify which cellular compartments contain each enzyme

    • Co-localization studies with known pathway components

  • Physiological context:

    • Measurement of expression levels under different growth conditions

    • Assessment of the contribution of each enzyme to total cellular cysteine desulfurase activity

    • Determination of which Fe-S containing proteins are affected by depletion of specific cysteine desulfurases

This comprehensive approach would help determine if SufS is the sole or primary cysteine desulfurase involved in Fe-S cluster biogenesis in S. aureus, or if there are functional redundancies with other enzymes under specific conditions .

What are the most promising research avenues for developing inhibitors targeting the SUF-like pathway in S. aureus?

Several promising research avenues could lead to effective inhibitors of the SUF-like pathway in S. aureus:

  • Structure-based drug design:

    • Leveraging the available crystal structure of SaSufS to design compounds that bind to the active site or allosteric sites

    • Virtual screening of compound libraries against multiple targets in the pathway

    • Fragment-based drug discovery focused on the PLP-binding pocket of SufS

    • Development of peptidomimetics that disrupt the SufS-SufU interface

  • Mechanism-based inhibitors:

    • Design of cysteine analogues that could form stable adducts with the PLP cofactor

    • Development of compounds that target the catalytic cysteine residue in SufS

    • Creation of transition-state analogues for the desulfuration reaction

    • Zinc-chelating compounds that disrupt SufU function without affecting host proteins

  • High-throughput screening approaches:

    • Cell-based screens for compounds that sensitize S. aureus to oxidative stress

    • In vitro enzymatic assays using purified SufS to identify direct inhibitors

    • Whole-cell screening under iron-limited conditions to identify compounds affecting Fe-S cluster biogenesis

    • Screens for synergy with existing antibiotics, particularly those inducing oxidative stress

  • Alternative modalities:

    • Antisense oligonucleotides targeting mRNA of SUF pathway components

    • CRISPR-Cas delivery systems to disrupt genes encoding SUF pathway proteins

    • Peptide inhibitors designed to disrupt protein-protein interactions in the pathway

    • Allosteric modulators that lock SufS in an inactive conformation

  • Combination approaches:

    • Dual inhibition of SUF pathway and DNA repair mechanisms to enhance sensitivity to oxidative stress

    • Targeting SUF pathway in combination with iron acquisition systems

    • Combining SUF pathway inhibitors with conventional antibiotics to prevent resistance development

The unusual characteristics of the S. aureus system, particularly the lower stimulation of SaSufS by SufU compared to other bacterial systems, might provide opportunities for selective targeting . Further structural and mechanistic studies of the complete SUF-like pathway in S. aureus will be essential to identify the most promising inhibition strategies.

How might comprehensive characterization of the entire SUF-like pathway in S. aureus advance our understanding of bacterial Fe-S cluster biogenesis?

Comprehensive characterization of the entire SUF-like pathway in S. aureus would significantly advance our understanding of bacterial Fe-S cluster biogenesis in several ways:

The unexpected finding that SaSufS is significantly less stimulated by SufU than BsSufS suggests there may be fundamental differences in pathway organization or regulation between these species . Comprehensive characterization would help determine whether this represents an adaptation to the pathogenic lifestyle of S. aureus and could reveal new principles of Fe-S cluster biogenesis in bacteria.

What are the key takeaways from current research on S. aureus cysteine desulfurase for the broader field of bacterial physiology?

The research on S. aureus cysteine desulfurase offers several significant insights for bacterial physiology:

  • Pathway essentiality and specificity: The SUF-like pathway represents the sole mechanism for Fe-S cluster biogenesis in most Gram-positive bacteria, including S. aureus, highlighting its potential as an antimicrobial target . This contrasts with the redundant pathways often found in Gram-negative bacteria.

  • Species-specific variations: The striking difference in stimulation of SufS by SufU between S. aureus and B. subtilis (1.5-fold vs. 15-fold) demonstrates that even highly conserved essential pathways can exhibit significant species-specific variations in their regulation and efficiency . This challenges the common assumption that essential pathways function similarly across related bacteria.

  • Complex interplay of pathway components: The hypothesis that SufBCD may be required for full stimulation of SaSufS activity highlights the intricate interplay between different components of the Fe-S cluster biogenesis machinery . This suggests that studying isolated components may not always reveal their true physiological behavior.

  • Connection to stress responses: The involvement of Fe-S clusters in DNA repair enzymes creates an important link between Fe-S cluster biogenesis and bacterial stress responses, particularly against oxidative stress encountered during infection . This connection underscores how seemingly unrelated pathways are integrated to support bacterial survival.

  • Structural conservation with functional divergence: Despite high structural similarity between SaSufS and BsSufS, their functional properties differ significantly . This illustrates how subtle structural differences can translate into significant functional diversity, a principle relevant to many aspects of bacterial physiology.

These insights extend beyond S. aureus and contribute to our general understanding of bacterial metabolism, adaptation, and evolution. They also highlight the importance of studying essential pathways in diverse bacterial species rather than extrapolating from model organisms alone .

How does understanding the SUF-like pathway in S. aureus contribute to broader strategies for combating antibiotic resistance?

Understanding the SUF-like pathway in S. aureus contributes to combating antibiotic resistance through several important mechanisms:

  • Novel target identification: The essentiality of the SUF-like pathway and its absence in humans makes it an attractive target for new antimicrobial development . As a system not targeted by current antibiotics, inhibitors of this pathway could help address the challenge of existing resistance mechanisms.

  • Resistance mechanism insights: Fe-S clusters are cofactors for enzymes involved in DNA repair, which can contribute to the emergence of antibiotic resistance through mutation . Understanding how the SUF-like pathway supports DNA repair could provide insights into the evolution of resistance and strategies to suppress it.

  • Combination therapy approaches: Inhibitors of the SUF-like pathway could sensitize S. aureus to oxidative stress, potentially enhancing the efficacy of antibiotics that induce such stress (like fluoroquinolones) . This synergistic approach could reduce the doses needed for effective treatment and slow resistance development.

  • Biofilm disruption: Fe-S cluster-containing proteins play roles in biofilm formation and maintenance, which contributes to antibiotic tolerance. Targeting the SUF-like pathway could potentially disrupt biofilms, making established infections more susceptible to conventional antibiotics.

  • Species-specific targeting: The unique features of the S. aureus SUF-like pathway, such as the lower stimulation of SaSufS by SufU, might allow for the development of selective inhibitors that target S. aureus specifically without affecting beneficial microbiota . This selectivity could reduce collateral damage to the microbiome that often promotes resistance development.

  • Pathogen fitness reduction: Even partial inhibition of the SUF-like pathway could reduce bacterial fitness during infection, potentially making S. aureus more susceptible to host immune clearance and reducing the selective pressure for antibiotic resistance development.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.